Individualized and structured sleep hygiene guidance for individuals with migraine and its effect on migraine-related disability and impact: partial analysis of results from a randomized clinical trial
Abstract
Introduction: Migraine is a debilitating primary headache disorder affecting more than one billion people worldwide. It is characterized by pulsating pain, usually unilateral, and is associated with functional disability. Sleep disorders, strongly influenced by lifestyle, are known triggers for migraine attacks. Although sleep hygiene—comprising behavioral and environmental changes—is recommended to reduce the frequency and intensity of migraine episodes, clinical evidence on its efficacy is limited, particularly when used as an isolated treatment for insomnia in migraine patients.
Objective: The aim of the study was to analyze the impact of individualized and structured sleep hygiene guidelines on migraine-related disability and outcomes using self-administered questionnaires.
Methods: A randomized, controlled, and open-label clinical trial was conducted with participants divided into two groups: (1) control and (2) sleep hygiene. Individuals aged 18–59 years with migraine were recruited from the Academic Headache Outpatient Clinic at PUCPR, Londrina-PR, Brazil. The control group received standard treatment, while the sleep hygiene group received personalized instructions to improve sleep quality. Assessments were performed at baseline (T0) and after 12 weeks (T12) through structured interviews and self-administered questionnaires, including Migraine Disability Assessment, Headache Impact Test 6, Allodynia Symptom Checklist, Generalized Anxiety Disorder 7-item, Beck…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 32 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.